GIBSON LABORATORIES LLC – Trademark Portfolio

Entity Type: 16

GIBSON LABORATORIES LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TRI-VALENT. The owner is based in St. Cloud, MN.

200 Cooper Avenue North

St. Cloud, MN 56303

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GIBSON LABORATORIES LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does GIBSON LABORATORIES LLC have?

GIBSON LABORATORIES LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.

What trademark classes does GIBSON LABORATORIES LLC file in?

GIBSON LABORATORIES LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are GIBSON LABORATORIES LLC's most well-known trademarks?

GIBSON LABORATORIES LLC's registered trademark portfolio includes well-known marks such as TRI-VALENT. These are among 1 currently registered trademark in the portfolio.

What is GIBSON LABORATORIES LLC's trademark registration success rate?

GIBSON LABORATORIES LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.